BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17328863)

  • 21. Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
    Mimori K; Ishii H; Inoue H; Barnard GF; Mori M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S205-9. PubMed ID: 19120899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
    Yutori H; Semba S; Komori T; Yokozaki H
    Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after FHIT gene transfer.
    Andriani F; Perego P; Carenini N; Sozzi G; Roz L
    Neoplasia; 2006 Jan; 8(1):9-17. PubMed ID: 16533421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.
    Zanesi N; Mancini R; Sevignani C; Vecchione A; Kaou M; Valtieri M; Calin GA; Pekarsky Y; Gnarra JR; Croce CM; Huebner K
    Cancer Res; 2005 Aug; 65(15):6576-82. PubMed ID: 16061637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line.
    Cavazzoni A; Galetti M; Fumarola C; Alfieri RR; Roz L; Andriani F; Carbognani P; Rusca M; Sozzi G; Petronini PG
    Cancer Lett; 2007 Feb; 246(1-2):69-81. PubMed ID: 16616810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells.
    Kim CH; Yoo JS; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
    Int J Cancer; 2006 Apr; 118(7):1692-8. PubMed ID: 16231322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling crosstalk of FHIT, CHK2 and p38 in etoposide induced growth inhibition in MCF-7 cells.
    Mir Mohammadrezaei F; Mohseni kouchesfehani H; Montazeri H; Gharghabi M; Ostad SN; Ghahremani MH
    Cell Signal; 2013 Jan; 25(1):126-32. PubMed ID: 23000346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.
    Weiske J; Albring KF; Huber O
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20344-9. PubMed ID: 18077326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
    Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
    Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
    Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
    Oncogene; 2006 May; 25(20):2860-72. PubMed ID: 16407838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
    Druck T; Cheung DG; Park D; Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Raso C; Green K; Huebner K; Croce CM
    Cell Death Dis; 2019 Feb; 10(3):147. PubMed ID: 30770797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Loss of exons of FHIT gene and FHIT protein expression in Yunnan tin miners with lung cancer].
    Ruan YH; Gao Q; Zhang L; Hua HR; Cheng JL; Jin KW
    Ai Zheng; 2007 Jun; 26(6):607-12. PubMed ID: 17562266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reduction of FHIT gene expression in primary lung cancer: relationship with the proliferation and apoptosis of tumor cell].
    Wang Y; Zhou Q; Zhang S; Yang H; Cheng N; Li L; Wu Z; Liu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):178-82. PubMed ID: 11402444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
    Jayachandran G; Sazaki J; Nishizaki M; Xu K; Girard L; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Nov; 67(21):10379-88. PubMed ID: 17974981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
    Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.
    Andriani F; Roz E; Caserini R; Conte D; Pastorino U; Sozzi G; Roz L
    J Thorac Oncol; 2012 Apr; 7(4):631-42. PubMed ID: 22425911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.